• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

A top analyst sees Pfizer and Moderna seizing a $38B prize as safety frets sideline global...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 20, 2021 at 11:22: AM
via While the wrangling over the relative safety of new, virally vectored Covid vaccines from J&J and AstraZeneca appears to be unending, analysts aren’t waiting around to see how the market will play out for the leaders.

article source
 




Top Bottom
Back
Quote